SciELO - Scientific Electronic Library Online

 
vol.20 número3Calidad de la atención de salud brindada en un servicio de rehabilitación integral de base comunitariaEstrategia de intervención educativa para mejorar la conducta en adolescentes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


MEDISAN

versión On-line ISSN 1029-3019

Resumen

COBIAN CABALLERO, Carlos Oliver; ACOSTA BROOKS, Soraida Cándida; MARTINEZ FERIA, Francisco  y  ROMERO GARCIA, Lázaro Ibrahim. Survival in patients with non-small cell lung cancer vaccinated with CIMAvax-EGF. MEDISAN [online]. 2016, vol.20, n.3, pp.320-328. ISSN 1029-3019.

An observational, descriptive and cross-sectional study in a first moment, and cohort analytic in a second time, of 95 patients with non-small cell lung cancer in advanced stages, assisted at "Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital and in 4 polyclinics of Santiago de Cuba, was carried out during the period 2006-2013, in order to estimate the survival in them after the vaccination with CIMAvax-EGF and to identify the factors associated to the mortality, for which Kaplan-Meier method and Cox regression were used, respectively. The global survival in 2 years was 20.7%, with a median of 13 months, as long as the survival a year after applying the vaccine was 36.5%. On the other hand, in the stage IIIB, the favorable response to the first line treatment, the chemotherapy-radiotherapy-vaccine combination and the immunization in 4 or more occasions, facilitated a significantly higher survival. The unfavorable reaction to the first therapeutic line constituted a prediction factor of death risk increase in the population affected

Palabras clave : global survival; non-small cell lung cancer; cancer vaccine; CIMAvax-EGF.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons